XBiotech Inc. SEC filings XBIT
XBiotech Inc. has 407 filings in SEC EDGAR's recent list, going back to Dec 10, 2014. Its latest annual report, Form ARS, was filed on Oct 2, 2026 for the period ended Oct 2, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 26, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2025 | Dec 5, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 15, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Oct 3, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Sep 2, 2025 | Aug 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 7, 2025 | Apr 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 31, 2024 | Dec 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Jan 4, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 15, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2022 | Jun 22, 2022 |
| 8-K |
Current report
Auditor change
|
May 13, 2022 | May 11, 2022 |
| 8-K |
Current report
Material agreement
|
Feb 2, 2022 | Feb 2, 2022 |
| 8-K |
Current report
Other events
|
Jul 6, 2021 | Jul 6, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2020 | Jun 26, 2020 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
|
Dec 30, 2019 | Dec 30, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 9, 2019 | Dec 7, 2019 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 16, 2019 | Jul 10, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2019 | Jun 19, 2019 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 3, 2019 | May 31, 2019 |
| 8-K |
Current report
Other events
|
May 30, 2019 | May 30, 2019 |
| 8-K |
Current report
Agreement ended
|
May 30, 2019 | May 30, 2019 |
| 8-K |
Current report
Material agreement
|
May 1, 2019 | Apr 30, 2019 |
| 8-K |
Current report
Agreement ended
|
Apr 3, 2019 | Mar 29, 2019 |
| 8-K |
Current report
Other events
|
Oct 24, 2018 | Oct 24, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2018 | Jun 19, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 11, 2018 | Apr 9, 2018 |
| 8-K |
Current report
Other events
|
Mar 23, 2018 | Mar 23, 2018 |
| 8-K |
Current report
Officer or director change
|
Mar 22, 2018 | Mar 20, 2018 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 1, 2018 | Feb 27, 2018 |
| 8-K |
Current report
Listing notice, Officer or director change
|
Jan 19, 2018 | Jan 16, 2018 |
| 8-K |
Current report
Other events
|
Jan 5, 2018 | Jan 5, 2018 |
| 8-K |
Current report
Other events
|
Nov 22, 2017 | Nov 20, 2017 |
| 8-K |
Current report
Other events
|
Sep 15, 2017 | Sep 14, 2017 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2017 | Jun 19, 2017 |
| 8-K |
Current report
Other events
|
Jun 9, 2017 | Jun 9, 2017 |
| 8-K |
Current report
Other events
|
May 18, 2017 | May 18, 2017 |
| 8-K |
Current report
Other events
|
Apr 28, 2017 | Apr 28, 2017 |
| 8-K |
Current report
Other events
|
Apr 21, 2017 | Apr 20, 2017 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Mar 3, 2017 | Mar 3, 2017 |
| 8-K |
Current report
Other events
|
Feb 8, 2017 | Feb 8, 2017 |
| 8-K |
Current report
Other events
|
Dec 16, 2016 | Dec 16, 2016 |
| 8-K/A | Amended current report | Dec 7, 2016 | Dec 5, 2016 |
| 8-K/A | Amended current report | Dec 6, 2016 | Dec 5, 2016 |
| 8-K |
Current report
Other events
|
Dec 5, 2016 | Dec 5, 2016 |
| 8-K |
Current report
Material agreement
|
Sep 26, 2016 | Sep 26, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2016 | Jun 20, 2016 |
| 8-K |
Current report
Other events
|
May 24, 2016 | May 24, 2016 |
| 8-K |
Current report
Officer or director change
|
May 3, 2016 | May 2, 2016 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2016 | Jan 8, 2016 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2015 | Jul 28, 2015 |
| 8-K |
Current report
Other events
|
Jul 16, 2015 | Jul 15, 2015 |
| 8-K |
Current report
Other events
|
Jul 1, 2015 | Jul 1, 2015 |
| 8-K |
Current report
Officer or director change
|
Jun 11, 2015 | Jun 8, 2015 |
| 8-K |
Current report
Other events
|
Jun 2, 2015 | May 28, 2015 |
| 8-K |
Current report
Other events
|
May 29, 2015 | May 26, 2015 |
| 8-K |
Current report
Other events
|
May 19, 2015 | May 18, 2015 |
| 8-K |
Current report
Officer or director change, Other events
|
May 5, 2015 | Apr 29, 2015 |
| 8-K |
Current report
Other events
|
Apr 20, 2015 | Apr 17, 2015 |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- XBIT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- British Columbia, Canada
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1626878
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.